Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?
Article in Cells (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model
Article in Journal of Clinical Investigation (February 2024)
Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma
Article in Cancer Letters (February 2020)